Millennium Management
SLDB icon

Millennium Management’s Solid Biosciences SLDB Stock Holding History

Millennium Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,000
Closed -$455K – 6458
2020
Q4 		$455K Buy
+4,000
New +$253K ﹤0.01% 4262
2019
Q1 		– Sell
-3,740
Closed -$1.5M – 4298
2018
Q4 		$1.5M Buy
+3,740
New +$1.76M ﹤0.01% 2374

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management's SLDB Position: Q1 2026 in Review

Millennium Management increased its Solid Biosciences (SLDB) stake by 212% in Q1 2026, buying an estimated $1.59M and bringing the position to 363,675 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3608.

Millennium Management first reported a position in SLDB in Q1 2018 and has held it in 26 quarters since. The position peaked at $9.8M in Q2 2024. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Millennium Management held 363,675 shares of Solid Biosciences worth $2.62M as of Q1 2026.
  • Millennium Management bought 247,043 Solid Biosciences shares in Q1 2026, an estimated $1.59M.
  • Solid Biosciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3608 holding.
  • Millennium Management first reported a position in Solid Biosciences in Q1 2018 and has held it in 26 quarters since.
  • Millennium Management's Solid Biosciences position peaked at $9.8M in Q2 2024.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.